首页
400-620-6333
应用
选项
-
Atoltivimab (anti-EBOV)简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2135632-29-8
-
Odesivimab (anti-EBOV)简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2135632-30-1
-
Cosfroviximab (anti-EBOV)简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1792982-57-0
-
Porgaviximab (anti-EBOV)种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1792982-55-8
-
Larcaviximab (anti-EBOV)种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1792982-56-9
-
Vilobelimab (anti-Complement C5)关联靶标: C5简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 非洲绿猴(African green monkey) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2250440-41-4
